Efficacy and safety study of PAXMAN and HairRepro MEDI Alpha for Chemotherapy Induced Alopecia for breast cancer
Not Applicable
Recruiting
- Conditions
- breast cancer
- Registration Number
- JPRN-UMIN000048637
- Lead Sponsor
- Department of Surgery and Science, Faculty of Medicine,Academic Assembly, University of Toyama
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 27
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with active multiple cancers 2) Patients with serious concomitant diseases (such as hepatic, renal, cardiac, hematological, or metabolic diseases) or psychiatric disorders 3) Patients who have been taking concomitantly banned drugs or study drugs within 4 weeks prior to the start of the study. 4) Patients with a history of allergy to Clozapine 5) Patients with eczema or other skin diseases on the head
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method